Item 5. Market for Registrant’s Common Equity
Item 5. Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is listed on the New York Stock Exchange with the ticker symbol “A”. As of December 2, 2024, there were 16,806 common stockholders of record.
The information required by this item with respect to equity compensation plans is included under the caption " Equity Compensation Plans" in our Proxy Statement for the Annual Meeting of Stockholders to be held March 13, 2025, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A, and is incorporated herein by reference.
STOCK PRICE PERFORMANCE GRAPH
The graph below shows the cumulative total stockholder return on our common stock with the cumulative total return of the S&P 500 Index and our peer group, consisting of all companies in the Health Care and Materials Indexes of the S&P 500, assuming an initial investment of $100 on October 31, 2019 and the reinvestment of all dividends.
Agilent’s stock price performance shown in the following graph is not indicative of future stock price performance. The data for this performance graph was compiled for us by Standard and Poor’s.
INDEXED RETURNS
Base Years Ending
Period
Company Name / Index 10/31/2019 10/31/2020 10/31/2021 10/31/2022 10/31/2023 10/31/2024
Agilent Technologies 100 135.93 210.90 186.45 140.29 178.06
S&P 500 100 109.71 156.79 133.88 147.46 203.52
Peer Group 100 112.04 153.60 153.06 149.45 181.18
31
Table of Contents
ISSUER PURCHASES OF EQUITY SECURITIES
The table below summarizes information about the company’s purchases, based on trade date, of its equity securities registered pursuant to Section 12 of the Exchange Act during the quarterly period ended October 31, 2024. The total number of shares of common stock purchased by the company during the fiscal year ended October 31, 2024 was 8,402,882 shares.
Period Total Number of
Shares of Common
Stock Purchased(1) Weighted Average
Price Paid per Share of
Common Stock(2) Total
Number of
Shares of Common
Stock Purchased as
Part of Publicly
Announced Plans or
Programs(1) Maximum
Approximate Dollar
Value of Shares of
Common Stock that
May Yet Be
Purchased Under the
Plans or Programs
(in millions)(1)
August 1, 2024 through
August 31, 2024
804,464 $ 140.19 804,464 $ 596
September 1, 2024 through
September 30, 2024
1,240,953 $ 137.98 1,240,953 $ 425
October 1, 2024 through
October 31, 2024
366,113 $ 139.28 366,113 $ 374
Total 2,411,530 $ 138.91 2,411,530
(1) On January 9, 2023, we announced that our board of directors had approved a share repurchase program (the "2023 repurchase program") designed, among other things, to reduce or eliminate dilution resulting from issuance of stock under the company's employee equity incentive programs. The 2023 repurchase program authorizes the purchase of up to $2.0 billion, excluding excise taxes, of our common stock at the company's discretion and has no fixed termination date. The 2023 repurchase program does not require the company to acquire a specific number of shares and may be suspended, amended or discontinued at any time. The 2023 repurchase program commenced on March 1, 2023, and also terminated and replaced the 2021 repurchase program. As of October 31, 2024, all repurchased shares to date have been retired.
(2) The weighted average price paid per share of common stock does not include the cost of commissions or excise taxes.
Item 6. [Reserved]